The Food and Drug Administration (FDA) is announcing a public advisory committee meeting involving the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee. This meeting, which will be held online due to COVID-19, is set for March 24-25, 2021. During the meeting, the committees will discuss a drug application by Pfizer for a treatment targeting moderate to severe osteoarthritis. The FDA has established a public docket to gather comments on regulatory issues, which will remain open until March 23, 2021.
Simple Explanation
The FDA is having an online meeting in March with experts who will give advice about a new drug from Pfizer to help with joint pain. They want people to share their thoughts and will keep a special place open for these comments until just before the meeting.